GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Metacare Co 118000.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

789

+3.82%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩32.82bn

FY2016FY2025

Net income

₩498.2m

FY2016FY2025

Free cash flow

−₩4.92bn

FY2016FY2025

Shareholders' equity

₩119.42bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩32.82bn₩20.21bn₩17.26bn₩19.10bn₩18.61bn₩26.90bn₩56.16bn₩34.47bn₩36.88bn₩11.23bn
Research and development——₩1.18bn———₩17.3m₩108.9m₩281.1m₩192.8m
Operating income₩1.32bn₩1.50bn₩1.01bn−₩240.5m−₩1.79bn−₩1.34bn−₩82.0m−₩6.63bn−₩3.19bn−₩5.75bn
Net income₩498.2m₩8.50bn−₩14.54bn−₩49.55bn₩7.74bn₩11.25bn−₩4.80bn−₩12.04bn−₩2.91bn−₩8.62bn
Diluted earnings per share14.18241.86-413.90-1,410.63220.33320.31-136.72-342.80-134.97-467.83

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩197.96bn₩157.82bn₩155.30bn₩189.86bn₩176.30bn₩138.29bn₩69.80bn₩61.44bn₩36.74bn₩28.84bn
Total liabilities₩76.98bn₩41.02bn₩17.60bn₩60.28bn₩56.90bn₩62.17bn₩33.87bn₩42.93bn₩18.03bn₩15.41bn
Debt₩22.98bn₩27.61bn—₩10.00bn——₩22.83bn₩30.37bn₩8.76bn₩8.70bn
Shareholders' equity₩119.42bn₩116.80bn₩105.91bn₩99.24bn₩119.40bn₩76.04bn₩35.82bn₩18.39bn₩18.52bn₩13.44bn
Shares outstanding35m35m35m35m35m35m35m35m22m18m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩2.42bn₩4.48bn−₩12.86bn−₩2.53bn−₩1.49bn₩3.79bn₩1.24bn−₩2.71bn−₩12.69bn−₩4.85bn
Capital spending−₩7.34bn−₩2.90bn−₩5.04bn−₩109.3m−₩26.5m−₩92.8m−₩61.7m−₩118.8m−₩78.8m−₩140.0m
Free cash flow−₩4.92bn₩1.58bn−₩17.89bn−₩2.64bn−₩1.52bn₩3.70bn₩1.18bn−₩2.83bn−₩12.77bn−₩4.99bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩8.76bn₩10.12bn₩10.31bn₩10.75bn₩5.76bn₩5.99bn₩5.60bn₩4.86bn
Operating income₩796.4m₩1.31bn—₩118.7m₩815.9m₩533.2m₩775.9m₩205.1m
Net income₩412.5m₩417.3m−₩3.72bn₩1.30bn₩2.93bn−₩8.1m−₩3.09bn₩479.2m
Diluted earnings per share11.7411.88-105.8736.8783.42-0.23-87.9413.64
Cash from operations₩980.0m₩2.85bn₩20.0m−₩117.0m₩2.16bn₩355.0m₩190.0m₩1.10bn
Capital spending−₩33.0m−₩5.0m−₩34.0m−₩309.0m−₩589.0m−₩6.41bn—−₩30.97bn
Free cash flow₩947.0m₩2.85bn−₩14.0m−₩426.0m₩1.57bn−₩6.05bn—−₩29.86bn
Total assets₩243.95bn₩188.61bn₩197.96bn₩199.79bn₩183.98bn₩173.95bn₩157.82bn₩130.58bn
Debt₩1.27bn—₩22.98bn₩50.50bn₩50.53bn₩50.56bn₩27.61bn₩6.86bn
Shareholders' equity₩125.42bn₩119.83bn₩119.42bn₩123.42bn₩122.13bn₩115.72bn₩116.80bn₩118.42bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue19.8%4.1%11.1%
Net income—-46.4%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin5.3%4.0%0.3%-8.0%
Net margin17.0%-61.6%-26.8%-25.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings215.111.7-9.7-3.768.378.8-231.4-55.5-231.5-206.8
Price to sales3.34.98.19.628.433.019.819.418.3158.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 11 Mar 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.